Healthcare Industry News: AngioDynamics
News Release - April 4, 2011
AngioDynamics Launches the Next Generation DuraMax(R) Stepped-Tip Chronic Dialysis CatheterCompany’s New DuraMax VascPak™ Kit Targets Vascular Access Centers
ALBANY, N.Y.--(Healthcare Sales & Marketing Network)-- AngioDynamics (NASDAQ:ANGO ) announced today the U.S. launch and initial shipments of the next generation DuraMax® stepped-tip chronic dialysis catheter and the DuraMaxVP (VascPak™) kit.
The DuraMax catheter provides optimal ease of insertion and high performance blood flow rates. It features a proprietary guidewire lumen designed to significantly improve catheter placement by securely fixing the guidewire in the center of the leading edge of the catheter at the insertion site.
“Approximately 30-50% of chronic dialysis catheters are placed over a guidewire, and DuraMax offers a significant improvement in ease of catheter placement,” said Shawn McCarthy, Senior Vice President and General Manager for AngioDynamics. “The DuraMax chronic dialysis catheter employs AngioDynamics’ highly innovative and proprietary Curved Tip™ Catheter Technology, which is designed to improve patient outcomes by providing higher blood flow over a longer timeframe at lower recirculation rates, even if the catheter becomes positioned against a vessel wall.”
The new DuraMaxVP (VascPak) product offers a streamlined component kit designed to appeal to vascular access centers and open this new segment for AngioDynamics. Up to 45% of all chronic dialysis catheter placements – more than 180,000 placements in 2011 – are performed in these outpatient centers.
AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, treatment of peripheral vascular disease and oncology procedures. AngioDynamics’ diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.AngioDynamics.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.